Alimera Sciences to Present at the Q1 Investor Summit Conference
Alimera Sciences (Nasdaq: ALIM) will present a corporate overview at the virtual Q1 Investor Summit Conference on March 9, 2022, at 8:45 AM ET. Rick Eiswirth, President and CEO, along with CFO Phil Jones, will be available for one-on-one investor meetings on the same day. This event highlights Alimera's commitment to partnering with patients and physicians to enhance retinal health and vision longevity. For more information and registration details, visit Alimera's official site.
- None.
- None.
ATLANTA, March 02, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will present a corporate overview at the Q1 Investor Summit Conference, which is being held virtually on March 8 – 9, 2022.
Mr. Eiswirth will deliver his corporate presentation on Wednesday, March 9, 2022 at 8:45 AM ET.
Additionally, Mr. Eiswirth and Phil Jones, Alimera’s Chief Financial Officer, will be available for one-on-one investor meetings on Wednesday, March 9, 2022.
Click here to register: Q1 Investor Summit - INVESTOR REGISTRATION
About Alimera Sciences, Inc.
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com | For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
FAQ
What is Alimera Sciences presenting at the Q1 Investor Summit Conference?
Who will be presenting at the Q1 Investor Summit for Alimera?
When is the Q1 Investor Summit Conference for Alimera Sciences?
How can I register for Alimera Sciences' Q1 Investor Summit presentation?